Author | Elizabeth M. Swisher, MD | OncLive

Author | Elizabeth M. Swisher, MD

Articles

Dr. Swisher on the Limitations of HRD as a Biomarker in Ovarian Cancer

April 23, 2020

Video

Elizabeth M. Swisher, MD, discusses the limitations of homologous recombination deficiency as a biomarker of response in ovarian cancer based on findings from the phase III VELIA trial.

Dr. Swisher on the Implications of the VELIA Trial in Ovarian Cancer

April 10, 2020

Video

Elizabeth M. Swisher, MD, discusses the implications of the phase III VELIA/GOG-3005 trial in ovarian cancer.

Dr. Swisher on How the VELIA Trial Stands Out in Ovarian Cancer Research

April 02, 2020

Video

Elizabeth M. Swisher, MD, discusses how the phase III VELIA/GOG-3005 trial compares with other trials examining up-front maintenance therapy in ovarian cancer.

x